Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, et al
From Hawaiis surging Wegovy queries to Nebraskas growing fascination with Zepbound, this data-driven overview uncovers the signals of a true weight-loss revolution across the United States
GLP-1 Weight Loss Drugs and Gastroparesis Ozempic (semaglutide) and other GLP-1 weight loss medications, have been associated with gastrointestinal side effects
Grunddal KV, Ratner CF, Svendsen B, Sommer F, Engelstoft MS, Madsen AN, et al
Beyond TRIUMPH: the TRANSCEND and SYNERGY programs Eli Lilly's retatrutide development extends beyond the TRIUMPH trials
Antimicrobial peptides and gut microbiota in homeostasis and pathology